MADISON, Wis.--(EON: Enhanced Online News)--BioForward, Wisconsin’s biohealth industry member association, today announced its 2017 Board of Directors. The BioForward leadership team represents the state’s world-class health sector, actively working on new innovations to improve healthcare worldwide.
“Our new Board members, combined with our strategic alignment along integrated health and collaborative solution-based initiatives, provides a visionary platform to achieve major results in 2017.”
“Wisconsin’s strength in the biosciences, medical devices, digital health and health services has unlimited potential, when we collaborate and innovate together,” said BioForward CEO Lisa Johnson. “Our new Board members, combined with our strategic alignment along integrated health and collaborative solution-based initiatives, provides a visionary platform to achieve major results in 2017.”
New Board members, approved by BioForward membership for the 2017-19 term include:
- Matt Anderson, Medical Director, Diagnostic Laboratories, Blood Center of Wisconsin
- Eric Floyd, President-Compliance Services & CSO, Dohmen Life Science Services
- Gary Frings, Chief Information Officer, Exact Sciences
- Mark Gehring, Co-founder, Chief Strategy Officer, HealthMyne
- John Hill, Chief Technology Officer and GM Engineering, GE Healthcare Imaging
The new Directors join twelve current board members that represent Wisconsin’s diverse biohealth industry: http://www.bioforward.org/meet-the-board/
“Each BioForward Director represents best-in-class products and services from their respective fields - everything from medical device and research to biopharma and digital health right here in Wisconsin,” said Joe Hammer, Chairman of BioForward and Chief Development Officer, The Dohmen Company. “Now we are converging to not only develop integrated health solutions, but also to accelerate our sector’s growth and attract tomorrow’s innovators to Wisconsin’s front door.”
More information can be found on the BioForward website here.